Contact
Please use this form to send email to PR contact of this press release:
Orphan designation: (3beta,24S)-25,25,25-trifluoro-3-methyl-26,27-dinorergost-5-ene-3,24-diol Treatment of Huntington's disease, 15/02/2023 Positive
TO: